Neuropace Inc at JPMorgan Healthcare Conference Transcript
Welcome. I'm Robbie Marcus, the med tech analyst at JPMorgan. Happy to introduce Mike Favet, our -- the CEO of NeuroPace, which is going to be our next presentation. Joining us later for Q&A is going to be Rebecca Kuhn and Irina Ridley. Rebecca is the CFO.
Reminder, just feel free to send me any questions. I can ask them in the Q&A portion. Otherwise, Mike, I'm going to turn it over to you and join you in a few minutes.
Very good. Thank you, Robbie. Thanks for the opportunity to present today. I'm going to start off. I've got the disclaimer that I'm sure everybody has seen before, and then I'm jumping into an overview.
The mission of NeuroPace is to transform lives of people living with drug-resistant epilepsy. We do that through a unique technology that has an implantable neurostimulation system that is actually able to monitor brain activity, respond in real time with custom therapy provided
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
